Workflow
发光材料
icon
Search documents
有研新材:预计2025年前三季度净利同比增长101%-127%
中证智能财讯有研新材(600206)10月10日晚间披露业绩预告,预计2025年前三季度归母净利润2.3亿元至2.6亿元,同比增长101%-127%;扣非净利润预计 1.55亿元至1.7亿元,同比增长62%-78%。以10月10日收盘价计算,有研新材目前市盈率(TTM)约为63.51倍-70.75倍,市净率(LF)约4.7倍,市销率 (TTM)约2.14倍。 以本次披露业绩预告均值计算,公司近年市盈率(TTM)图如下所示: 近年来市盈率变化情况(倍) 300 @50 200 150 120.65 100 70.06 68.75 54x29 50 58.2 37x88 0 2020-06-30 ' 2020-12-37 2021-06-30 <- 12-37 2021-12-3- 5-12-37 2n- -○- 公司 -○- 行业均值 100 ହ 90 80 70 63a87 60 50 40 30 26.3 23x62 22d4 20 17016 10 4.88 0 2027-12-37 1 -06-30 ' 2021-06-30 2-06-30 -12-37 <- 12-37 . 1-12-37 2n- ← ...
博苑股份9月22日获融资买入2382.65万元,融资余额1.13亿元
Xin Lang Cai Jing· 2025-09-23 01:45
9月22日,博苑股份涨1.41%,成交额2.84亿元。两融数据显示,当日博苑股份获融资买入额2382.65万 元,融资偿还3645.92万元,融资净买入-1263.28万元。截至9月22日,博苑股份融资融券余额合计1.13 亿元。 融资方面,博苑股份当日融资买入2382.65万元。当前融资余额1.13亿元,占流通市值的4.39%。 融券方面,博苑股份9月22日融券偿还0.00股,融券卖出0.00股,按当日收盘价计算,卖出金额0.00元; 融券余量0.00股,融券余额0.00元。 资料显示,山东博苑医药化学股份有限公司位于山东省寿光市侯镇海洋化工园区新海路与大九路路口北 200米,成立日期2008年8月6日,上市日期2024年12月11日,公司主营业务涉及专业从事精细化学品研 发、生产、销售及资源综合利用的高新技术企业,主营业务包括有机碘化物、无机碘化物、贵金属催化 剂、发光材料、六甲基二硅氮烷等产品的研发、生产、销售,并基于资源综合利用资质与工艺技术优势 开展含碘、贵金属等物料的回收利用业务,为客户提供贵金属催化剂、六甲基二硅氮烷等加工服务。主 营业务收入构成为:碘化物74.56%,特种功能化学品12.79% ...
博苑股份跌2.03%,成交额1.17亿元,主力资金净流出226.47万元
Xin Lang Cai Jing· 2025-09-15 02:09
Core Viewpoint - The stock of Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has shown significant price increases this year, with a year-to-date rise of 108.17% as of September 15, 2023, despite a recent decline in trading [1][2]. Group 1: Company Overview - Shandong Boyuan Pharmaceutical Chemical Co., Ltd. was established on August 6, 2008, and is located in Shouguang City, Shandong Province [2]. - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2]. - The revenue composition of the company includes 74.56% from iodides, 12.79% from specialty functional chemicals, 9.94% from trading, and 2.72% from other sources [2]. Group 2: Financial Performance - For the first half of 2025, the company achieved operating revenue of 747 million yuan, representing a year-on-year growth of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.04 million yuan [2]. - The company has distributed a total of 88.41 million yuan in dividends since its A-share listing [3]. Group 3: Stock Performance and Trading Activity - As of September 15, 2023, the stock price was 80.64 yuan per share, with a market capitalization of 10.777 billion yuan [1]. - The stock has experienced a trading volume of 1.17 billion yuan, with a turnover rate of 4.25% [1]. - The stock has appeared on the "Dragon and Tiger List" four times this year, with the most recent net buy of 51.18 million yuan on September 9, 2023 [1].
博苑股份9月4日获融资买入2775.30万元,融资余额1.18亿元
Xin Lang Cai Jing· 2025-09-05 02:14
Group 1 - The core viewpoint of the news highlights the recent stock performance of Baoyuan Co., which experienced a decline of 5.72% on September 4, with a trading volume of 484 million yuan [1] - On September 4, Baoyuan Co. had a financing buy-in amount of 27.75 million yuan and a financing repayment of 99.64 million yuan, resulting in a net financing outflow of 71.89 million yuan [1] - As of September 4, the total margin balance for Baoyuan Co. was 118 million yuan, accounting for 5.84% of its circulating market value [1] Group 2 - Baoyuan Co. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with its main business involving the research, production, and sales of fine chemicals [2] - The company's main revenue sources include iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] - For the first half of 2025, Baoyuan Co. reported a revenue of 747 million yuan, representing a year-on-year growth of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.04 million yuan [2] Group 3 - Baoyuan Co. has cumulatively distributed 88.41 million yuan in dividends since its A-share listing [3]
博苑股份:截至2025年6月30日,公司参与制定3项行业标准与12项团体标准
Zheng Quan Ri Bao Wang· 2025-09-01 10:46
Core Viewpoint - The company, Boyuan Co., Ltd. (301617), maintains a leading position in the iodide and luminescent materials market, with its hexamethyldisilazane business gradually increasing market share [1] Group 1: Product Applications and Quality - The company's products are widely used in pharmaceuticals, pesticides, food, and optoelectronic materials, recognized for their stable quality and excellent performance by customers [1] Group 2: Industry Standards and Influence - By June 30, 2025, the company is set to participate in the formulation of 3 industry standards and 12 group standards, reflecting its industry influence and technical authority, contributing to industry regulation and innovation [1]
博苑股份8月22日获融资买入8520.40万元,融资余额1.52亿元
Xin Lang Cai Jing· 2025-08-25 01:46
Group 1 - On August 22, Boyuan Co., Ltd. saw a stock price increase of 8.61% with a trading volume of 598 million yuan [1] - The financing buy amount for Boyuan Co., Ltd. on the same day was 85.204 million yuan, with a net financing purchase of 36.4176 million yuan [1][2] - As of August 22, the total financing and securities lending balance for Boyuan Co., Ltd. was 152 million yuan, accounting for 9.36% of its circulating market value [2] Group 2 - Boyuan Co., Ltd. is located in Shouguang City, Shandong Province, and was established on August 6, 2008, with its listing date set for December 11, 2024 [2] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane [2] - The revenue composition of Boyuan Co., Ltd. includes iodides (74.56%), specialty functional chemicals (12.79%), trading business (9.94%), and others (2.72%) [2] Group 3 - As of August 20, the number of shareholders for Boyuan Co., Ltd. was 13,200, a decrease of 0.14% from the previous period [3] - The average circulating shares per person increased by 0.14% to 2,524 shares [3] - For the first half of 2025, Boyuan Co., Ltd. achieved an operating income of 747 million yuan, a year-on-year increase of 7.39%, while the net profit attributable to shareholders decreased by 19.09% to 99.0429 million yuan [3] Group 4 - Boyuan Co., Ltd. has cumulatively distributed 88.408 million yuan in dividends since its A-share listing [4]
调研速递|博苑股份接受民生证券等1家机构调研 精彩要点披露
Xin Lang Cai Jing· 2025-08-25 01:46
Group 1 - The core viewpoint of the news is that Boyuan Co., Ltd. is actively engaging with investors to discuss its iodine and iodine derivative products, which are essential in various fields such as medicine, agriculture, and industry [1] - Iodine and its derivatives are widely used in X-ray contrast agents, disinfectants, and LCD/LED screen polarizers, with the pharmaceutical manufacturing, X-ray contrast agents, and liquid crystal panel manufacturing being the three main downstream applications, accounting for approximately 63% of global consumption [1] - The global iodine industry is predominantly concentrated in Chile, Japan, and the United States, which together account for nearly 95% of global sales, with some production also occurring in Russia and China [1] Group 2 - Boyuan Co., Ltd. possesses several core competitive advantages, including a circular economy model that integrates resource recycling with its main business, enhancing customer loyalty through comprehensive service [2] - The company has a stable and professional R&D team with over 30 years of industry experience, holding 51 patents as of June 30, 2025, and has established a leading technical strength in the industry [2] - Boyuan Co., Ltd. has built a comprehensive quality control system, ensuring stable product quality and maintaining long-term cooperation with many well-known enterprises, thereby establishing a good reputation [2] - The company is a market leader in iodine compounds and luminescent materials, gradually increasing its market share in hexamethyldisilazane, and has participated in the formulation of multiple industry standards, demonstrating its industry influence [2] - Boyuan Co., Ltd. has obtained various qualifications and established a safety production management system, continuously recognized as an advanced environmental protection unit, which has earned customer trust [2]
震惊!国产COF封装龙头四川上达电子破产清算,员工全部解聘
Ju Chao Zi Xun· 2025-06-06 07:13
Core Viewpoint - Sichuan Shangda Electronics Co., Ltd. has filed for bankruptcy liquidation due to financial difficulties exacerbated by industry challenges and rapid technological changes in the consumer electronics sector [1][4]. Company Overview - Sichuan Shangda was established in June 2019 with a registered capital of 300 million yuan, primarily focusing on flexible printed circuit boards (FPC) and other related products [2][3]. - The company became a key supplier for major domestic smartphone brands like Huawei, Xiaomi, and Vivo, achieving an annual production capacity of 250,000 pieces shortly after its establishment [2][3]. Financial Challenges - As of the bankruptcy filing, Sichuan Shangda reported total assets of 687 million yuan and liabilities of 826 million yuan, indicating a negative net asset of approximately 138 million yuan [4][8]. - The company faced a significant decline in orders for high-end FPC and COF due to a global downturn in consumer electronics demand and price wars in the electric vehicle supply chain [3][4]. - Initial production yield at the Sichuan facility was only 75%, below the industry breakeven point of 85%, leading to slow capacity ramp-up and financial strain [3][4]. Operational Issues - The company attempted to alleviate liquidity issues through equipment mortgage financing, but faced challenges due to poor asset liquidity and tightened credit conditions in the semiconductor sector [4]. - A decision was made to cease operations and terminate all employee contracts by May 30, 2025, due to the inability to sustain operations amid a funding crisis [4][7]. Legal Disputes - Sichuan Shangda is involved in multiple legal disputes with various companies over contracts related to sales, construction, and financing, indicating ongoing operational and financial complications [8].
印蒙稀土合作能复制中国模式?
Sou Hu Cai Jing· 2025-06-03 02:06
Core Viewpoint - The collaboration between India and Mongolia in the rare earth sector faces significant challenges and is unlikely to replicate China's successful model due to resource, technological, transportation, and geopolitical constraints [2][9]. Resource Challenges - Mongolia possesses approximately 31 million tons of rare earth oxide reserves (20% of global total), but faces difficulties in resource development due to complex ore compositions and inadequate infrastructure [3][4]. - India's rare earth reserves are only 6.9 million tons (about 5.7% of global share) and are primarily low-grade, making extraction costly and economically unviable [4]. Technological Gaps - China's rare earth industry has a comprehensive technological advantage, controlling over 85% of global refining capacity and excelling in extraction and processing technologies [5][6]. - India and Mongolia lack advanced rare earth processing capabilities, with India only able to perform basic processing and Mongolia having no industrial-grade separation facilities [5][6]. Transportation Issues - Proposed transportation routes to bypass China face high costs and risks, including reliance on underdeveloped infrastructure and geopolitical instability [7][8]. - The three planned routes (via Russia, Central Asia-Iran, and air transport) are fraught with logistical challenges and would significantly increase costs compared to traditional routes [7][8]. Geopolitical Constraints - The geopolitical landscape complicates India-Mongolia cooperation, with India seeking to reduce dependence on China while Mongolia aims to balance influences from China and Russia [8]. - The lack of trust and inconsistent diplomatic policies hinder long-term collaboration, making it difficult for India and Mongolia to establish a stable partnership [8]. Conclusion - The challenges faced by India and Mongolia in the rare earth sector far outweigh potential opportunities, and the likelihood of successfully replicating China's dominance is low [9]. - A more pragmatic approach would involve leveraging China's existing infrastructure and technology for efficient resource development and processing [9].
北方稀土(600111) - 北方稀土关于参股公司在全国中小企业股份转让系统挂牌的公告
2025-02-27 11:00
证券代码:600111 证券简称:北方稀土 公告编号:2025—007 中国北方稀土(集团)高科技股份有限公司 关于参股公司在全国中小企业股份转让系统挂牌的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 近日,中国北方稀土(集团)高科技股份有限公司(以下简称公 司)从参股公司福建省金龙稀土股份有限公司(以下简称金龙稀土) 获悉,其股票将于 2025 年 2 月 28 日起在全国中小企业股份转让系统 挂牌公开转让。具体事项公告如下: 一、金龙稀土基本情况 公司名称:福建省金龙稀土股份有限公司 统一社会信用代码:9135082115791410XF 注册资本:247,500 万元人民币 (除危险化学品)销售;稀土、环境、化工材料、废料及产品的检验; 稀土类检测技术咨询及培训服务。(依法须经批准的项目,经相关部 门批准后方可开展经营活动) 二、金龙稀土挂牌情况 证券简称:金龙稀土 证券代码:874673 法定代表人:钟可祥 有限公司成立日期:2000 年 3 月 3 日 股份公司成立日期:2023 年 11 月 30 日 住所 ...